Caxton Associates (New York)’s Eastman Chemical EMN Stock Holding History

Caxton Associates (New York)’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-83,636	Closed	-$9.36M	–	545
2024 Q3	$9.36M	Buy	83,636 +37,222	+80%	+$3.72M	0.35%	31
2024 Q2	$4.55M	Buy	+46,414	New	+$4.61M	0.16%	74
2019 Q1	–	Sell	-12,356	Closed	-$903K	–	408
2018 Q4	$903K	Buy	+12,356	New	+$985K	0.14%	65
2017 Q4	–	Sell	-6,900	Closed	-$624K	–	381
2017 Q3	$624K	Buy	+6,900	New	+$587K	0.02%	262
2014 Q2	–	Sell	-35,000	Closed	-$3.02M	–	198
2014 Q1	$3.02M	Buy	+35,000	New	+$2.87M	0.19%	96

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caxton Associates (New York)'s EMN Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Eastman Chemical (EMN) in Q4 2024, closing a stake of 83,636 shares — an estimated $9.36M sold.

Caxton Associates (New York) first reported a position in EMN in Q1 2014 and held it in 5 quarters. The position peaked at $9.36M in Q3 2024. 785 funds tracked by Wall St. Rank hold EMN as of Q4 2024.

Caxton Associates (New York) reported no remaining Eastman Chemical position as of Q4 2024 after selling out during the quarter.
Caxton Associates (New York) sold 83,636 Eastman Chemical shares in Q4 2024, an estimated $9.36M.
Caxton Associates (New York) first reported a position in Eastman Chemical in Q1 2014 and held it in 5 quarters.
Caxton Associates (New York)'s Eastman Chemical position peaked at $9.36M in Q3 2024.
785 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.